X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2621) 2621
Publication (376) 376
Book Chapter (12) 12
Book Review (11) 11
Dissertation (11) 11
Conference Proceeding (5) 5
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1421) 1421
index medicus (1132) 1132
humans (1109) 1109
male (1095) 1095
rats (774) 774
dopamine (667) 667
neurosciences (641) 641
receptors, dopamine d3 (524) 524
pharmacology & pharmacy (477) 477
receptors, dopamine d2 - metabolism (474) 474
female (464) 464
receptors, dopamine d3 - metabolism (459) 459
dopamine antagonists - pharmacology (452) 452
mice (419) 419
dopamine agonists - pharmacology (387) 387
dose-response relationship, drug (351) 351
rats, sprague-dawley (337) 337
psychiatry (324) 324
receptors, dopamine d3 - antagonists & inhibitors (321) 321
dopamine d3 receptors (316) 316
article (278) 278
schizophrenia (269) 269
adult (259) 259
dopamine d2 receptor antagonists (259) 259
dopamine receptors (230) 230
receptors, dopamine d2 - agonists (225) 225
receptors (220) 220
d3 receptor (219) 219
ligands (219) 219
receptor (208) 208
receptors, dopamine d2 - drug effects (207) 207
dopamine d2 receptors (201) 201
receptors, dopamine d3 - agonists (198) 198
biochemistry & molecular biology (197) 197
dopamine - metabolism (193) 193
brain (190) 190
vitamin d (185) 185
rats, wistar (183) 183
cocaine (182) 182
middle aged (181) 181
phenols (181) 181
piperazines - pharmacology (174) 174
brain - metabolism (171) 171
motor activity - drug effects (167) 167
d-3 receptor (165) 165
receptors, dopamine d3 - genetics (164) 164
expression (163) 163
nucleus-accumbens (155) 155
dopamine d3 receptor (151) 151
receptors, dopamine d2 - genetics (150) 150
tetrahydronaphthalenes - pharmacology (150) 150
receptors, dopamine d2 - physiology (148) 148
cells, cultured (146) 146
dopamine d (145) 145
rodents (139) 139
signal transduction (137) 137
vitamin d3 (136) 136
analysis (135) 135
antagonists (135) 135
binding (135) 135
gene expression (135) 135
chemistry, medicinal (134) 134
rat (132) 132
mice, knockout (126) 126
proteins (126) 126
pharmacology (125) 125
corpus striatum - metabolism (124) 124
mice, inbred c57bl (124) 124
research (124) 124
structure-activity relationship (122) 122
antipsychotic agents - pharmacology (120) 120
addiction (119) 119
behavior, animal - drug effects (119) 119
cell biology (119) 119
clinical neurology (119) 119
brain - drug effects (116) 116
calcitriol - pharmacology (116) 116
in-vivo (116) 116
receptors, dopamine d3 - physiology (114) 114
disease models, animal (112) 112
antagonist (110) 110
positron-emission tomography (110) 110
positron emission tomography (109) 109
cell line (108) 108
schizophrenia - drug therapy (108) 108
time factors (108) 108
biomedicine (105) 105
parkinsons-disease (104) 104
activation (103) 103
cho cells (103) 103
cricetinae (103) 103
medicine (103) 103
receptors, calcitriol - metabolism (100) 100
reward (100) 100
young adult (99) 99
reinforcement (98) 98
radioligand assay (97) 97
parkinson's disease (96) 96
pet (96) 96
quinpirole - pharmacology (95) 95
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2620) 2620
Japanese (20) 20
French (5) 5
Chinese (4) 4
Russian (3) 3
German (2) 2
Polish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 11/2012, Volume 68, Issue 11, pp. 1465 - 1472
Buspirone, a partial 5HT1A agonist and D2 and D3 antagonist, has shown promising antiemetic efficacy when given parenterally in animal models, but its efficacy... 
Biomedicine | Buspirone | Pharmacology/Toxicology | Randomised clinical trial | Antiemetic | Postoperative nausea and vomiting | CATS | MANAGEMENT | 5-HT1A RECEPTORS | ONDANSETRON | AGONISTS | FLESINOXAN | PROPHYLAXIS | ANXIOLYTICS | PHARMACOLOGY & PHARMACY | 5-HT(1A) RECEPTOR | CISPLATIN-INDUCED EMESIS | Anti-Anxiety Agents - administration & dosage | Injections, Intravenous | Buspirone - blood | Dopamine Antagonists - pharmacokinetics | Humans | Middle Aged | Receptors, Dopamine D3 - metabolism | Antiemetics - administration & dosage | Male | Buspirone - pharmacokinetics | Receptors, Dopamine D2 - metabolism | Dopamine Antagonists - administration & dosage | Incidence | Dose-Response Relationship, Drug | Young Adult | Anti-Anxiety Agents - pharmacokinetics | Buspirone - administration & dosage | Antiemetics - pharmacokinetics | Antiemetics - therapeutic use | Aged, 80 and over | Adult | Anti-Anxiety Agents - adverse effects | Antiemetics - adverse effects | Female | Anti-Anxiety Agents - therapeutic use | Buspirone - adverse effects | Receptors, Dopamine D3 - antagonists & inhibitors | Buspirone - therapeutic use | Receptor, Serotonin, 5-HT1A - metabolism | Postoperative Nausea and Vomiting - epidemiology | Double-Blind Method | Dopamine Antagonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Postoperative Nausea and Vomiting - prevention & control | Receptor, Serotonin, 5-HT1A - chemistry | Buspirone - analogs & derivatives | Dopamine Antagonists - adverse effects | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Aged | Dopamine D2 Receptor Antagonists | Postoperative Nausea and Vomiting - blood | Prevention | Complications and side effects | Buspirone hydrochloride | Adults | Nausea | Analysis | Postoperative period | Vomiting | Clinical trials | Pharmacology | Drug therapy | Clinical outcomes
Journal Article
Journal Article
Expert Opinion on Therapeutic Patents, ISSN 1354-3776, 03/2013, Volume 23, Issue 3, pp. 363 - 381
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 897 - 10
Journal Article
PLOS ONE, ISSN 1932-6203, 05/2019, Volume 14, Issue 5, p. e0216220
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2020, Volume 10, Issue 1, pp. 1 - 9
Dopamine is a neurotransmitter of great physiological relevance. Disorders in dopaminergic signal transduction are associated with psychiatric and neurological... 
Drug abuse | Parkinson's disease | Dopamine | Neurodegenerative diseases | Mental disorders | Dopamine D3 receptors | Schizophrenia | Signal transduction | Ligands | Transduction | Dopamine D2 receptors | Movement disorders | Neurotransmission | Crystal structure
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0136267
Journal Article